» Articles » PMID: 32844279

The Pro-apoptotic Domain of BIM Protein Forms Toxic Amyloid Fibrils

Overview
Publisher Springer
Specialty Biology
Date 2020 Aug 27
PMID 32844279
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

BIM is a key apoptotic protein, participating in diverse cellular processes. Interestingly, recent studies have hypothesized that BIM is associated with the extensive neuronal cell death encountered in protein misfolding diseases, such as Alzheimer's disease. Here, we report that the core pro-apoptotic domain of BIM, the BIM-BH3 motif, forms ubiquitous amyloid fibrils. The BIM-BH3 fibrils exhibit cytotoxicity, disrupt mitochondrial functions, and modulate the structures and dynamics of mitochondrial membrane mimics. Interestingly, a slightly longer peptide in which BIM-BH3 was flanked by four additional residues, widely employed as a model of the pro-apoptotic core domain of BIM, did not form fibrils, nor exhibited cell disruptive properties. The experimental data suggest a new mechanistic role for the BIM-BH3 domain, and demonstrate, for the first time, that an apoptotic peptide forms toxic amyloid fibrils.

Citing Articles

Assessing the Catalytic Role of Native Glucagon Amyloid Fibrils.

Nandi A, Zhang A, Arad E, Jelinek R, Warshel A ACS Catal. 2024; 14(7):4656-4664.

PMID: 39070231 PMC: 11270920. DOI: 10.1021/acscatal.4c00452.


In silico design of potential Mcl-1 peptide-based inhibitors.

Faraji N, Daly N, Arab S, Khosroushahi A J Mol Model. 2024; 30(4):108.

PMID: 38499818 DOI: 10.1007/s00894-024-05901-8.


Proteomic analysis of the IPF mesenchymal progenitor cell nuclear proteome identifies abnormalities in key nodal proteins that underlie their fibrogenic phenotype.

Yang L, Gilbertsen A, Smith K, Xia H, Higgins L, Guerrero C Proteomics. 2022; 22(13-14):e2200018.

PMID: 35633524 PMC: 9541064. DOI: 10.1002/pmic.202200018.


Long Non-Coding RNA PNKY Modulates the Development of Choroidal Neovascularization.

Shi L, Han X, Liu C, Li X, Lu S, Jiang Q Front Cell Dev Biol. 2022; 10:836031.

PMID: 35265621 PMC: 8899849. DOI: 10.3389/fcell.2022.836031.

References
1.
Sionov R, Vlahopoulos S, Granot Z . Regulation of Bim in Health and Disease. Oncotarget. 2015; 6(27):23058-134. PMC: 4695108. DOI: 10.18632/oncotarget.5492. View

2.
Biancalana M, Koide S . Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta. 2010; 1804(7):1405-12. PMC: 2880406. DOI: 10.1016/j.bbapap.2010.04.001. View

3.
Margaret Harris M, Coon Z, Alqaeisoom N, Swords B, Holub J . Targeting anti-apoptotic Bcl2 proteins with scyllatoxin-based BH3 domain mimetics. Org Biomol Chem. 2015; 14(2):440-446. DOI: 10.1039/c5ob02080h. View

4.
Oren O, Ben Zichri S, Taube R, Jelinek R, Papo N . Aβ42 Double Mutant Inhibits Aβ42-Induced Plasma and Mitochondrial Membrane Disruption in Artificial Membranes, Isolated Organs, and Intact Cells. ACS Chem Neurosci. 2020; 11(7):1027-1037. DOI: 10.1021/acschemneuro.9b00638. View

5.
Finder V, Glockshuber R . Amyloid-beta aggregation. Neurodegener Dis. 2007; 4(1):13-27. DOI: 10.1159/000100355. View